Cutaneous Oncology News

Based on a variant’s impact on type VII collagen protein function, patients with recessive dystrophic epidermolysis bullosa can be categorized into clinically meaningful subgroups to better guide disease management, according to a study.

Generation Z adults love skin care but are less enthusiastic about sunscreen and sun safety practices, putting them at a higher risk for skin cancer, according to a new survey from the American Academy of Dermatology.

Younger patients and those with T1b melanomas on the face, ear or scalp should undergo sentinel lymph node biopsies, according to a study.

Actinic keratosis lesions were reduced and quality of life improved following once-daily topical tirbanibulin treatment, according to a study.

Procedural factors influence post-inflammatory hyperpigmentation following Mohs micrographic surgery among patients with skin of color, according to a study.

Merck has discontinued the vibostolimab and pembrolizumab coformulation arm of its phase 3 trial for the adjuvant treatment of patients with resected high-risk melanoma, the company announced in a press release.

Immunotherapy is a life-saving treatment for melanoma, but not all individuals have access to this treatment, according to a study.

As April is Skin Cancer Awareness Month, Healio has compiled the top skin cancer news and stories from 2024.

Researchers found an inexplicable rise of melanoma incidences despite an unchanging mortality rate, according to a study.

Alcohol does more than affect your liver — it can affect your skin too.